Specifically, UBE2T overexpression resulted in the upregulation of the mTORC1 and TNFA signaling pathways, which facilitated cell cycle progression and inhibited apoptosis, thereby promoting breast cancer cell growth. Here, UBE2T is linked to breast carcinoma.